US Patent 8362209 Telomerase reverse transcriptase variant
Patent 8362209 was granted and assigned to University of Medicine and Dentistry of New Jersey on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+375 characters)
Article
Patent abstract
The present invention relates to nucleic and amino acid sequences of a novel variant of the telomerase reverse transcriptase. More particularly, the present invention is directed to a novel variant of human telomerase reverse transcriptase, which displays properties distinct from those of wildtype telomerase reverse transcriptase, and methods of use thereof.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Janine H. Santos0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08362209 Telomerase reverse transcriptase variant US Patent 8362209 Telomerase reverse transcriptase variant
Infobox
Patent Number
08362209
Patent Number
8362209
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08362209 Telomerase reverse transcriptase variant
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08362209
Date of patent
January 29, 2013
Patent application number
12733277
Date Filed
August 25, 2008
Patent primary examiner
Find more entities like US Patent 8362209 Telomerase reverse transcriptase variant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
